Ac immune's alzheimer's vaccine generates potent anti-ptau antibody response in a phase 1b/2a study

Interim results of aci-35.030 vaccination show high titers of antigen-specific antibodies at potentially therapeutic levels in 100% of older patients with early alzheimer's disease
ACIU Ratings Summary
ACIU Quant Ranking